Navigation Links
VivaScope(R) Confocal Imager May Eliminate Need for Routine Skin Biopsies for Dermatology Patients
Date:10/16/2007

ROCHESTER, N.Y., Oct. 16 /PRNewswire/ -- Many routine surgical biopsies could become a thing of the past as dermatologists may soon be sharing, reviewing and diagnosing noninvasive digital images of skin cells via the Internet, using Lucid Inc.'s VivaNet(TM) telemedicine server and its VivaScope(R) confocal imagers.

The technology, which relies on using special microscopes to digitally image a patient's skin, may bypass the need to surgically biopsy many patients. "VivaScope imaging sessions require only 5 to 10 minutes of a physician's assistant's time," said Jay Eastman, Ph.D., CEO, Lucid Inc. (http://www.lucid-tech.com).

The cellular resolution images may then be used by physicians to assist in forming a clinical judgment for a variety of skin conditions, including, for example, melanoma, basal cell carcinoma, actinic keratoses, and contact dermatitis.

A typical VivaScope imaging session produces two types of images of the patient's skin: dermatoscopic-quality, full-color macroscopic pictures, and microscopic, cellular resolution images. Like a routine biopsy, the images can then be read by a dermatologist or a pathologist and the diagnosis presented to the patient.

"Just as MRI and CT scans have largely eliminated the need for routine exploratory surgery, in-vivo confocal imaging may one day eliminate the need for routine invasive skin biopsy," Eastman stated.

Improving Quality of Life for Dermatology Patients

Already, dozens of Lucid's VivaScopes are in regular use throughout the U.S. and Europe. "Lucid's VivaScope(R) 1500 has the capability of imaging virtually all types of skin cancers, which makes it useful for many everyday procedures in a dermatology practice," stated Dr. Harold Rabinovitz, a Florida based dermatologist who specializes in skin cancer. "The VivaScope is an incredible diagnostic tool and now routinely aids me in the clinical evaluation of potential skin cancers."

The Company is also developing an Internet-based application, the Lucid VivaNet(TM), to enable the transfer of VivaScope digital images between practitioners and pathologists for rapid review of confocal images. The VivaNet technology conforms to DICOM (Digital Imaging and Communications in Medicine), an internationally accepted standard for the secure storage, retrieval and transfer of medical images, and it complies with federal HIPAA requirements for privacy and integrity of medical data.

Ultimately, the VivaNet could make VivaScope images available for review by other dermatologists and pathologists -- anywhere in the world -- in minutes, not days -- thus enabling rapid, real-time professional collaboration. The ultimate goal is that practitioners will rapidly receive a pathologic interpretation of confocal images from a VivaScope session, potentially assisting the practitioner in arriving at a clinical judgment while the patient is still in the doctor's office, Eastman said.

"It's our hope that the VivaScope and VivaNet will improve the quality of life for dermatology patients by eliminating the need for painful, invasive skin biopsies and drastically reducing the time required for diagnosis and treatment," Eastman said.

For information on Lucid's VivaScope or VivaNet technology, contact Lucid by phone at 585-239-9800, by email at info@lucid-tech.com, or on the web at http://www.lucid-tech.com. Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Jay Eastman, Ph.D. http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=62055


'/>"/>
SOURCE Lucid Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Satellite Imagery to monitor the Social Impact Of Geographical Changes
2. Three Teslas magnetic resonance imager acquired. Shot in the arm for research
3. Jumping genes eliminate sections of DNA
4. a New Pill Can eliminate menstruation
5. Bush Urged To Press India To Eliminate Medical Tariffs
6. Elephantiasis Is Eliminated In Egypt Due To Mass Drug Administration
7. Campaign to Eliminate Cervical Cancer
8. Inculcating Positive Thoughts Could Eliminate Depressive Mood
9. Researchers claim That Regular Use Of Hib Vaccine In Africa Could Eliminate H. Influenza totally.
10. Hospitals To Get Extra Consultants To Eliminate A&E Crisis
11. HIV discrimination in workplace should be eliminated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... Tiny Transitions ( tinytransitions.com ), ... in-home and online newborn sleep consultations . , “We are seeing now, ... company owner Courtney Zentz, a pediatric sleep professional, post-partum doula and certified lactation ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... book on the fallacy of an obligatory tithe, and the freedom experienced when ... is the creation of published author, Lysa M. Harrison. , Published by Christian ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... you brush more effectively even on the go. Their electric toothbrushes aggressively attack ... gum inflammation, with UV sanitizing technology. Combining leading edge Enke technology with a ...
(Date:9/22/2017)... ... 22, 2017 , ... Egg freezing and embryo freezing are ... a slight statistical advantage for live births, frozen eggs offer many advantages, depending ... undergoing medical treatment or who are concerned about the decline of their fertility ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Sept. 6, 2017 Eli Lilly and Company ... present new data for galcanezumab and lasmiditan, two investigational ... International Headache Society (IHC) taking place Sept. 7-10 in ... will highlight new, long-term data from an open-label study ... galcanezumab (120 mg and 240 mg) for the prevention ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology: